News

Find News

Filter articles

Showing 2861 to 2870 of 2887 results

US appeals court reverses £482 million Johnson & Johnson verdict

US08-04-2013

The US Court of Appeals for the Federal Circuit has reversed a $482 million jury decision against Johnson & Johnson subsidiary Cordis, ruling that its Cypher stent did not infringe a patent held by radiologist Bruce Saffran.

Merck fails to ban Indian diabetes generics

India08-04-2013

Merck is the latest multinational pharma company to suffer a setback in India, after failing to win an injunction against generic versions of two anti-diabetes drugs.

India's Novartis ruling: the implications for patent owners

India03-04-2013

India’s Supreme Court has rejected pharmaceutical company Novartis’s application to patent an updated version of its leukaemia drug Glivec, agreeing with the Comptroller General that it lacked novelty.

India publishes final biotech patent guidelines

India02-04-2013Legal developments

India’s patent office has published final guidelines for examining biotechnology patents, after accepting comments on a draft version published in December.

AstraZeneca settles Crestor patent dispute

US27-03-2013

UK pharmaceutical company AstraZeneca has reached a settlement with Actavis and Egis Pharmaceuticals that delays the release of generic versions of its cholesterol treatment Crestor.

AstraZeneca signs five-year licensing deal for RNA therapeutics

US22-03-2013

AstraZeneca has signed a five-year licensing deal with Moderna Therapeutics, a US biotechnology company specialising in drugs using RNA therapeutics.

Bayer sues Glenmark over generic Finacea

US15-03-2013

Pharmaceutical companies Bayer, Intendis and Intraserv have filed a patent infringement lawsuit against Glenmark after it applied to market a generic version of rosacea treatment Finacea.

Mylan signs generic truce with Shionogi and Andrx

Japan, US15-03-2013

Generic drug maker Mylan has struck a deal with pharma companies Shionogi and Andrx to resolve a patent dispute over their diabetes drug Fortamet.

Janssen sues Hetero over generic HIV treatment

14-03-2013

Janssen Products, a subsidiary of Johnson & Johnson, has sued Indian pharmaceutical company Hetero Drugs for applying to market a generic version of its HIV treatment Prezista.

1st Annual Life Sciences Law Forum: confusion over SPCs

07-03-2013

Recent CJEU judgements on the interpretation of SPC regulations are not clear and have left judges frustrated, said Huw Evans, partner at Norton Rose LLP, at the 1st Annual Life Sciences Law Forum in London.

Showing 2861 to 2870 of 2887 results

LSIPR